Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RFS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Early research (Phase 1)Study completedNCT00113113
What this trial is testing

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Who this might be right for
Tumors
Astex Pharmaceuticals, Inc. 54
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableUnknownNCT01327807
What this trial is testing

Cure Cystinosis International Registry

Who this might be right for
CystinosisNephropathic CystinosisRenal Fanconi Syndrome
Cystinosis Research Foundation 750
Testing effectiveness (Phase 2)Study completedNCT00005873
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Astex Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT06287541
What this trial is testing

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Testing effectiveness (Phase 2)Study completedNCT00006230
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC 51
Not applicableStudy completedNCT03886389
What this trial is testing

Breast Cancer Diet Intervention Study

Who this might be right for
Early-stage Breast CancerCarbohydrate EngorgementProliferation+2 more
Helse Stavanger HF 80
Testing effectiveness (Phase 2)Study completedNCT00005826
What this trial is testing

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 17
Testing effectiveness (Phase 2)UnknownNCT00005876
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery

Who this might be right for
Esophageal CancerGastric Cancer
Astex Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT07006467
What this trial is testing

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

Who this might be right for
Critical Limb Ischemia (CLI)
Stentit 10
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000